Methodist Health System
The human BK polyomavirus is a significant risk factor for renal transplant dysfunction and allograft loss. The prevalence of BK viremia (BKV) following kidney transplantation is estimated to be 10-20%.
The human BK polyomavirus is a significant risk factor for renal transplant dysfunction and allograft loss. The prevalence of BK viremia (BKV) following kidney transplantation is estimated to be 10-20%. Immunosuppression reduction is the management cornerstone for BKV and has been shown to be effective at clearing the virus while maintaining graft function in both kidney alone and simultaneous kidney-pancreas transplant recipients. However, there is a lack of published data on the prevalence and outcomes in simultaneous liver-kidney (SLK) transplant recipients.
Inclusion Criteria: * Age 18 years or older * SLK recipients transplanted at MDMC between 2015-2020 Exclusion Criteria: * Below 18 years of age * Patients who did not undergo SLK transplant at MDMC
Simultaneous Liver-Kidney Transplant
Arctuva estimate
Actual pay is set by the research site.
Verify or correct the compensation shown for this listing.